{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:20:42Z","timestamp":1793996442253,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science and Technology Major Project","award":["2013ZX10002004"],"award-info":[{"award-number":["2013ZX10002004"]}]},{"name":"Key Project from Beijing Municipal Science and Technology Commission","award":["D121100003912003"],"award-info":[{"award-number":["D121100003912003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12072-017-9819-9","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T04:37:28Z","timestamp":1505363848000},"page":"412-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A brief review on prognostic models of primary biliary cholangitis"],"prefix":"10.1007","volume":"11","author":[{"given":"Sha","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-8890","authenticated-orcid":false,"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"issue":"1","key":"9819_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145\u201372.","journal-title":"J Hepatol"},{"key":"9819_CR2","first-page":"61","volume":"4","author":"N Al-Harthy","year":"2012","unstructured":"Al-Harthy N, Kumagi T. Natural history and management of primary biliary cirrhosis. Hepat Med. 2012;4:61\u201371.","journal-title":"Hepat Med"},{"issue":"4","key":"9819_CR3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","volume":"123","author":"M Prince","year":"2002","unstructured":"Prince M, Chetwynd A, Newman W, Metcalf JV, James OF. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002;123(4):1044\u201351.","journal-title":"Gastroenterology"},{"issue":"7","key":"9819_CR4","first-page":"1165","volume":"113","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Takikawa H, Mochida S, Koike K, Miwa H, Shimosegawa T. Changing nomenclature for PBC from \u201cPrimary Biliary Cirrhosis\u201d to \u201cPrimary Biliary Cholangitis\u201d. Nihon Shokakibyo Gakkai Zasshi. 2016;113(7):1165\u20137.","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"issue":"33","key":"9819_CR5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4254\/wjh.v8.i33.1419","volume":"8","author":"YQ Huang","year":"2016","unstructured":"Huang YQ. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World J Hepatol. 2016;8(33):1419\u201341.","journal-title":"World J Hepatol"},{"issue":"8","key":"9819_CR6","doi-asserted-by":"crossref","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","volume":"95","author":"Y Peng","year":"2016","unstructured":"Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2016;95(8):e2877.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"9819_CR7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/tri.12877","volume":"30","author":"AK Singal","year":"2017","unstructured":"Singal AK, Fang X, Kaif M, et al. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation. Transpl Int. 2017;30(5):454\u201362.","journal-title":"Transpl Int"},{"issue":"1","key":"9819_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","volume":"308","author":"J Roll","year":"1983","unstructured":"Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med. 1983;308(1):1\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"9819_CR9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","volume":"89","author":"E Christensen","year":"1985","unstructured":"Christensen E, Neuberger J, Crowe J, et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology. 1985;89(5):1084\u201391.","journal-title":"Gastroenterology"},{"issue":"1","key":"9819_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 1989;10(1):1\u20137.","journal-title":"Hepatology"},{"issue":"2","key":"9819_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","volume":"19","author":"P Angulo","year":"1999","unstructured":"Angulo P, Lindor KD, Therneau TM, et al. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver. 1999;19(2):115\u201321.","journal-title":"Liver"},{"issue":"3","key":"9819_CR12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Par\u00e9s","year":"2006","unstructured":"Par\u00e9s A, Caballer\u00eda L, Rod\u00e9s J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology. 2006;130(3):715\u201320.","journal-title":"Gastroenterology"},{"issue":"3","key":"9819_CR13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48(3):871\u20137.","journal-title":"Hepatology"},{"issue":"4","key":"9819_CR14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper EM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009;136(4):1281\u20137.","journal-title":"Gastroenterology"},{"issue":"6","key":"9819_CR15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00535-009-0051-9","volume":"44","author":"N Azemoto","year":"2009","unstructured":"Azemoto N, Abe M, Murata Y, et al. Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis. J Gastroenterol. 2009;44(6):630\u20134.","journal-title":"J Gastroenterol"},{"issue":"10","key":"9819_CR16","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105(10):2186\u201394.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"9819_CR17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1478-3231.2011.02678.x","volume":"32","author":"N Momah","year":"2012","unstructured":"Momah N, Silveira MG, Jorgensen R, Sinakos E, Lindor KD. Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis. Liver Int. 2012;32(5):790\u20135.","journal-title":"Liver Int"},{"issue":"6","key":"9819_CR18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouill\u00e8res O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55(6):1361\u20137.","journal-title":"J Hepatol"},{"issue":"7","key":"9819_CR19","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149(7):1804\u201312.","journal-title":"Gastroenterology"},{"issue":"3","key":"9819_CR20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63(3):930\u201350.","journal-title":"Hepatology"},{"issue":"6","key":"9819_CR21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","volume":"60","author":"PJ Trivedi","year":"2014","unstructured":"Trivedi PJ, Bruns T, Cheung A, et al. Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response. J Hepatol. 2014;60(6):1249\u201358.","journal-title":"J Hepatol"},{"issue":"9","key":"9819_CR22","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/jgh.12938","volume":"30","author":"AW Chan","year":"2015","unstructured":"Chan AW, Chan RC, Wong GL, et al. New simple prognostic score for primary biliary cirrhosis: albumin-bilirubin score. J Gastroenterol Hepatol. 2015;30(9):1391\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"9819_CR23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/jlts.2000.6503","volume":"6","author":"WR Kim","year":"2000","unstructured":"Kim WR, Wiesner RH, Poterucha JJ, et al. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl. 2000;6(4):489\u201394.","journal-title":"Liver Transpl"},{"issue":"1","key":"9819_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50(1):291\u2013308.","journal-title":"Hepatology"},{"issue":"22","key":"9819_CR25","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","volume":"324","author":"RE Poupon","year":"1991","unstructured":"Poupon RE, Balkau B, Eschw\u00e8ge E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study group. N Engl J Med. 1991;324(22):1548\u201354.","journal-title":"N Engl J Med"},{"issue":"3","key":"9819_CR26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","volume":"29","author":"P Angulo","year":"1999","unstructured":"Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology. 1999;29(3):644\u20137.","journal-title":"Hepatology"},{"issue":"6","key":"9819_CR27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","volume":"32","author":"C Corpechot","year":"2000","unstructured":"Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology. 2000;32(6):1196\u20139.","journal-title":"Hepatology"},{"issue":"1","key":"9819_CR28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","volume":"39","author":"RE Poupon","year":"2003","unstructured":"Poupon RE, Lindor KD, Par\u00e9s A, Chazouill\u00e8res O, Poupon R, Heathcote EJ. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol. 2003;39(1):12\u20136.","journal-title":"J Hepatol"},{"issue":"2","key":"9819_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C, Carrat F, Bahr A, Chr\u00e9tien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005;128(2):297\u2013303.","journal-title":"Gastroenterology"},{"issue":"9","key":"9819_CR30","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","volume":"101","author":"BPC Ter","year":"2006","unstructured":"Ter BPC, Schalm SW, Hansen BE, van Buuren HR. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol. 2006;101(9):2044\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"9819_CR31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.26322","volume":"58","author":"LN Zhang","year":"2013","unstructured":"Zhang LN, Shi TY, Shi XH, et al. Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study. Hepatology. 2013;58(1):264\u201372.","journal-title":"Hepatology"},{"issue":"3","key":"9819_CR32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","volume":"144","author":"M Carbone","year":"2013","unstructured":"Carbone M, Mells GF, Pells G, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;144(3):560\u20139.","journal-title":"Gastroenterology"},{"issue":"2","key":"9819_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","volume":"65","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, Lammers WJ, van Buuren HR, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. 2016;65(2):321\u20139.","journal-title":"Gut"},{"issue":"6","key":"9819_CR34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","volume":"98","author":"K Balasubramaniam","year":"1990","unstructured":"Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology. 1990;98(6):1567\u201371.","journal-title":"Gastroenterology"},{"issue":"6","key":"9819_CR35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","volume":"20","author":"TC Mahl","year":"1994","unstructured":"Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol. 1994;20(6):707\u201313.","journal-title":"J Hepatol"},{"issue":"1","key":"9819_CR36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","volume":"94","author":"J Springer","year":"1999","unstructured":"Springer J, Cauch-Dudek K, O\u2019Rourke K, Wanless IR, Heathcote EJ. Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol. 1999;94(1):47\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"9819_CR37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","volume":"45","author":"F Yang","year":"2017","unstructured":"Yang F, Yang Y, Wang Q, et al. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210. Aliment Pharmacol Ther. 2017;45(5):733\u201343.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-017-9819-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T06:24:56Z","timestamp":1505888696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-017-9819-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["9819"],"URL":"https:\/\/doi.org\/10.1007\/s12072-017-9819-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}